The Net Asset Value (NAV) per unit decreased from $5.89 as of December 31, 2024, to $5.71 as of December 31, 2025, a decline of $0.18 per unit. Net investment income significantly decreased to $4,962,433 for the year ended December 31, 2025, from $12,202,266 in the prior year. Total investment income declined to $18,506,243 in 2025 from $25,856,989 in 2024, primarily due to reclassification of income from certain investments and more investments being placed on non-accrual status. The company recorded net change in unrealized depreciation on investments of $(7,361,847) in 2025, a reversal from net change in unrealized appreciation of $1,737,905 in 2024. Net realized losses on investments increased to $(6,094,524) in 2025 from $(1,471,793) in 2024. No distributions were paid to unitholders during the year ended December 31, 2025; only two special distributions totaling $4,181,278 were paid in February and March 2024, with regular monthly distributions suspended since June 2023. The unit repurchase program remains suspended for general requests, with repurchases limited solely to requests made in connection with the death or disability of a unitholder, and further limited by proceeds from the Distribution Reinvestment Plan (DRP), which are currently zero due to no distributions. The company faces significant liquidity constraints due to ongoing challenges with borrowers' ability to repay amounts owed. The largest investment, Blue Arrow Biojet Holdings, LLC, represents 27.0% of the total portfolio's fair value ($70,740,611) and accrues paid-in-kind (PIK) interest. The number of Watch List investments increased to 22 companies (57.1% of the total portfolio's fair value) in 2025, from 19 companies (57.2%) in 2024. 19 portfolio companies were on non-accrual status (51.3% of the total portfolio's fair value) as of December 31, 2025, up from 14 companies (37.4%) in 2024. A portion of the investment in TriLinc Peru S.A.C. was sold to an affiliated entity for $1.0 million, resulting in a realized loss of approximately $74,000. Total debt outstanding as of December 31, 2025, was approximately $2.9 million, solely related to a repurchase obligation, resulting in a debt to equity ratio of 1.0%.